Cargando…
Prevention of risks associated with inappropriate use/unnecessary consumption of medicines()
In the code of public health, misuse is defined as intentional and inappropriate use of a medicine or product, which is not in accordance with the terms of the marketing authorisation or the registration as well as with good practice recommendations. Very often this involves an individual or the int...
Autores principales: | Cracowski, Jean-Luc, Muller, Sophie, Anglade, Isabelle, Bonnefond, Gilles, Bouhanick, Béatrice, Bouquet, Sylvain, Cabut, Sandrine, Daynès, Pascale, Denis, Bernard, Durand, Dorothée, Jonville-Béra, Annie-Pierre, Lahouegue, Amir, Léo, Magali, Micallef, Joëlle, Molimard, Mathieu, Penfornis, Catherine, Querol-Ferrer, Valérie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783759/ https://www.ncbi.nlm.nih.gov/pubmed/35078658 http://dx.doi.org/10.1016/j.therap.2022.01.003 |
Ejemplares similares
-
Prévention des risques liés à un usage inapproprié/consommation inutile des médicaments()
por: Cracowski, Jean-Luc, et al.
Publicado: (2022) -
Health crisis: What opportunities for clinical drug research?()
por: Deplanque, Dominique, et al.
Publicado: (2022) -
Platform trials()
por: Roustit, Matthieu, et al.
Publicado: (2023) -
Crise sanitaire : quelles opportunités pour la recherche clinique sur le médicament ?()
por: Deplanque, Dominique, et al.
Publicado: (2022) -
Les essais plateformes()
por: Roustit, Matthieu, et al.
Publicado: (2023)